OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Clinical Immunology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee	548
The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity	223
The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee	165
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study	109
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses	108
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency	99
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain	98
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage	92
STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions	71
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona	70
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best	67
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia	64
STING-Mediated Lung Inflammation and Beyond	58
Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study	57
Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency	51
Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency	50
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome	49
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma	49
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients	46
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital	44
COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico	43
A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19	42
COVID-19 in Patients with Primary Immunodeficiency	41
IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2	39
Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2	38

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study	38
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncr	37
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β	37
Consensus Middle East and North Africa Registry on Inborn Errors of Immunity	37
Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance	36
Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia	35
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis	34